Bausch Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Bausch Health Companies
BHC Stock  USD 7.04  0.11  1.54%   
Bausch Health financial statements provide useful quarterly and yearly information to potential Bausch Health Companies investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Bausch Health financial statements helps investors assess Bausch Health's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Bausch Health's valuation are summarized below:
Gross Profit
6.8 B
Profit Margin
(0)
Market Capitalization
2.6 B
Enterprise Value Revenue
2.3952
Revenue
9.6 B
We have found one hundred twenty available fundamental signals for Bausch Health Companies, which can be analyzed and compared to other ratios and to its rivals. Investors should ensure to validate all of Bausch Health's prevailing performance against the performance from 2010 to 2025 to make sure the company is sustainable down the road. As of March 18, 2025, Market Cap is expected to decline to about 2.5 B. In addition to that, Enterprise Value is expected to decline to about 17.7 B

Bausch Health Total Revenue

9.99 Billion

Check Bausch Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bausch Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 884.5 M, Interest Expense of 1.5 B or Selling General Administrative of 3.5 B, as well as many indicators such as Price To Sales Ratio of 0.3, Dividend Yield of 0.0522 or Days Sales Outstanding of 95.37. Bausch financial statements analysis is a perfect complement when working with Bausch Health Valuation or Volatility modules.
  
Check out the analysis of Bausch Health Correlation against competitors.

Bausch Health Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets15.4 B26.5 B27 B
Pretty Stable
Short and Long Term Debt Total2.5 B2.7 B17.6 B
Very volatile
Other Current Liabilities3.5 B3.4 B2.6 B
Slightly volatile
Total Current Liabilities7.1 B6.8 B4 B
Slightly volatile
Property Plant And Equipment Net1.9 B1.8 B1.3 B
Slightly volatile
Net Debt1.4 B1.5 B16.8 B
Very volatile
Accounts Payable688.8 M656 M404.9 M
Slightly volatile
Cash1.2 B1.2 B809.3 M
Slightly volatile
Non Current Assets Total13 B20.7 B23.1 B
Pretty Stable
Non Currrent Assets Other241.5 M363 M377.3 M
Very volatile
Cash And Short Term Investments1.2 B1.2 B809.9 M
Slightly volatile
Net Receivables2.2 B2.1 B1.7 B
Slightly volatile
Common Stock Shares Outstanding251.3 M368 M324.5 M
Slightly volatile
Liabilities And Stockholders Equity15.4 B26.5 B27 B
Pretty Stable
Non Current Liabilities Total11.5 B20.1 B21.1 B
Slightly volatile
Other Current Assets900.9 M858 M648.3 M
Slightly volatile
Other Stockholder Equity222.3 M234 M290.8 M
Pretty Stable
Total Liabilities13.5 B26.8 B24.5 B
Slightly volatile
Property Plant And Equipment Gross4.1 B3.9 B1.9 B
Slightly volatile
Total Current Assets6.1 B5.8 B4.2 B
Slightly volatile
Short Term Debt2.8 B2.7 B616.1 M
Slightly volatile
Intangible Assets5.8 B5.6 B10 B
Pretty Stable
Inventory1.7 B1.6 B1 B
Slightly volatile
Common Stock Total Equity7 B11.9 B8.7 B
Slightly volatile
Short Term Investments93 M88.5 M55.1 M
Slightly volatile
Common Stock6.3 B10.5 B8.6 B
Slightly volatile
Other Liabilities1.3 B1.1 B1.8 B
Very volatile
Long Term Debt14.3 B18.9 B19.1 B
Slightly volatile
Good Will7.4 B11.1 B10.7 B
Slightly volatile
Property Plant Equipment2.2 B2.1 B1.3 B
Slightly volatile
Long Term Debt Total21.5 B23.4 B19.9 B
Slightly volatile
Capital Surpluse173.7 M182.8 M311.2 M
Slightly volatile
Deferred Long Term Liabilities172.7 M181.8 M1.5 B
Slightly volatile
Long Term Investments5.1 M8.2 M6.8 M
Slightly volatile
Non Current Liabilities Other992.7 M1 B908.1 M
Slightly volatile
Deferred Long Term Asset Charges97.8 M167.9 M119.4 M
Slightly volatile
Short and Long Term Debt2.8 B2.7 B608.3 M
Slightly volatile
Cash And Equivalents797.4 M507.6 M756.1 M
Pretty Stable
Net Invested Capital19.4 B20.3 B27 B
Slightly volatile
Capital Stock11.3 B10.5 B10.3 B
Slightly volatile

Bausch Health Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization884.5 M1.5 B1.6 B
Pretty Stable
Selling General Administrative3.5 B3.3 B2 B
Slightly volatile
Total Revenue10 B9.5 B7.4 B
Slightly volatile
Gross Profit7.1 B6.7 B5.3 B
Slightly volatile
Other Operating Expenses8.5 B8.1 B6.4 B
Slightly volatile
Cost Of Revenue2.9 B2.8 B2.1 B
Slightly volatile
Total Operating Expenses5.6 B5.3 B4.3 B
Slightly volatile
Research Development646.8 M616 M403.5 M
Slightly volatile
Selling And Marketing Expenses430.3 M718.8 M399.5 M
Slightly volatile
Non Recurring12.8 M13.5 M573.6 M
Pretty Stable
Interest Income31.4 M33 M730.1 M
Slightly volatile
Reconciled Depreciation1.5 B1.3 B2.3 B
Slightly volatile
Extraordinary Items780 M877.5 M956.7 M
Slightly volatile

Bausch Health Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow584.3 M962 M898.4 M
Slightly volatile
Depreciation941.3 M1.3 B1.7 B
Very volatile
Capital Expenditures176.6 M337 M269.5 M
Pretty Stable
End Period Cash Flow626.9 M1.2 B951.6 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.30.31162.3287
Slightly volatile
Dividend Yield0.05220.05790.06
Pretty Stable
Days Sales Outstanding95.3782.065687.9175
Slightly volatile
Average Payables4.3 M5 M5.4 M
Slightly volatile
Stock Based Compensation To Revenue0.02070.01580.0149
Very volatile
Capex To Depreciation0.250.2660.2145
Slightly volatile
EV To Sales0.450.46854.6364
Slightly volatile
Inventory Turnover2.791.74422.5997
Slightly volatile
Days Of Inventory On Hand130209161
Slightly volatile
Payables Turnover3.374.24095.0687
Very volatile
Sales General And Administrative To Revenue0.30.25920.2927
Slightly volatile
Research And Ddevelopement To Revenue0.09650.06470.0608
Very volatile
Capex To Revenue0.03360.03540.0429
Slightly volatile
Cash Per Share3.373.20922.3363
Slightly volatile
Days Payables Outstanding14686.0676106
Slightly volatile
Intangibles To Total Assets0.440.62730.6946
Very volatile
Net Debt To EBITDA0.920.965714.2096
Pretty Stable
Current Ratio0.810.85521.1659
Slightly volatile
Receivables Turnover3.694.44774.1946
Slightly volatile
Capex Per Share0.460.91580.7817
Very volatile
Revenue Per Share27.1625.864121.2368
Slightly volatile
Interest Debt Per Share10.4911.03854.409
Very volatile
Debt To Assets0.09580.10080.6422
Slightly volatile
Enterprise Value Over EBITDA2.742.884328.4192
Slightly volatile
Graham Number48.045.7141.0766
Slightly volatile
Operating Cycle195291244
Pretty Stable
Days Of Payables Outstanding14686.0676106
Slightly volatile
Long Term Debt To Capitalization0.990.940.9104
Slightly volatile
Total Debt To Capitalization2.011.91681.0364
Slightly volatile
Cash Ratio0.170.17490.2324
Slightly volatile
Days Of Inventory Outstanding130209161
Slightly volatile
Days Of Sales Outstanding95.3782.065687.9175
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.90.7890.8416
Pretty Stable
Fixed Asset Turnover3.995.34725.5151
Very volatile
Enterprise Value Multiple2.742.884328.4192
Slightly volatile
Debt Ratio0.09580.10080.6422
Slightly volatile
Price Sales Ratio0.30.31162.3287
Slightly volatile
Asset Turnover0.430.35890.2863
Slightly volatile
Gross Profit Margin0.810.70770.7264
Very volatile

Bausch Health Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.5 B2.6 B12 B
Slightly volatile
Enterprise Value17.7 B21.9 B30.6 B
Pretty Stable

Bausch Fundamental Market Drivers

Forward Price Earnings1.5463
Cash And Short Term Investments1.2 B

Bausch Upcoming Events

22nd of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Bausch Health Financial Statements

Bausch Health stakeholders use historical fundamental indicators, such as Bausch Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although Bausch Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bausch Health's assets and liabilities are reflected in the revenues and expenses on Bausch Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bausch Health Companies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue2.4 B2.5 B
Total Revenue9.5 B10 B
Cost Of Revenue2.8 B2.9 B
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.26  0.30 
Research And Ddevelopement To Revenue 0.06  0.10 
Capex To Revenue 0.04  0.03 
Revenue Per Share 25.86  27.16 
Ebit Per Revenue 0.16  0.17 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
CRMSalesforce
CRMSalesforce
When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:
How To Invest In Bausch
Details
Is Bausch Stock a good investment?
Details
What is Bausch Health's Net Worth?
Details
Largest Pharmaceuticals Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Bausch Health Correlation against competitors.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Health. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.61)
Earnings Share
(0.13)
Revenue Per Share
26.155
Quarterly Revenue Growth
0.063
Return On Assets
0.0433
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY